Skip to Main Content

Close

Journals
Professional Books
ADA Standards of Care
ADA Meeting Abstracts
Clinical Compendia
Podcasts
Professional News

header search

search input Search input auto suggest

filter your search

Search

Advanced Search

Menu

Current
Browse
Info & About
Podcasts
Subscriptions
Alerts
Submit
- Submit a Manuscript
- Submit a Cover Image

Skip Nav Destination

Issues

Select Decade

Select Year

Issue

Volume 52, Issue 9

1 September 2003

ISSN 0012-1797

EISSN 1939-327X

In this Issue

Metabolism
Signal Transduction
Obesity Studies
Immunology and Transplantation
Islet Studies
Pathophysiology
Complications
Genetics
Brief Genetics Reports
Erratum

Search within issue:

Search within issue

Metabolism

Enhanced Fat Oxidation Through Physical Activity Is Associated With Improvements in Insulin Sensitivity in Obesity

Bret H. Goodpaster; Andreas Katsiaras; David E. Kelley

View articletitled, Enhanced Fat Oxidation Through Physical Activity Is Associated With Improvements in Insulin Sensitivity in Obesity

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2191-2197. doi:https://doi.org/10.2337/diabetes.52.9.2191

Cortisol Acts Through Central Mechanisms to Blunt Counterregulatory Responses to Hypoglycemia in Conscious Rats

Darleen A. Sandoval; Ling Ping; Anthony Ray Neill; Sachiko Morrey; Stephen N. Davis

View articletitled, Cortisol Acts Through Central Mechanisms to Blunt Counterregulatory Responses to Hypoglycemia in Conscious Rats

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2198-2204. doi:https://doi.org/10.2337/diabetes.52.9.2198

Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans

Zhi-Ping Chen; Terry J. Stephens; Sid Murthy; Benedict J. Canny; Mark Hargreaves; Lee A. Witters; Bruce E. Kemp; Glenn K. McConell

View articletitled, Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2205-2212. doi:https://doi.org/10.2337/diabetes.52.9.2205

Higher Insulin Concentrations Are Required to Suppress Gluconeogenesis Than Glycogenolysis in Nondiabetic Humans

Aron Adkins; Rita Basu; Mai Persson; Betty Dicke; Pankaj Shah; Adrian Vella; W. Frederick Schwenk; Robert Rizza

View articletitled, Higher Insulin Concentrations Are Required to Suppress Gluconeogenesis Than Glycogenolysis in Nondiabetic Humans

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2213-2220. doi:https://doi.org/10.2337/diabetes.52.9.2213

Regulation and Function of the Muscle Glycogen-Targeting Subunit of Protein Phosphatase 1 (G_M) in Human Muscle Cells Depends on the COOH-Terminal Region and Glycogen Content

Carlos Lerín; Eulàlia Montell; Teresa Nolasco; Cathy Clark; Matthew J. Brady; Christopher B. Newgard; Anna M. Gómez-Foix

View articletitled, Regulation and Function of the Muscle Glycogen-Targeting Subunit of Protein Phosphatase 1 (G<sub>M</sub>) in Human Muscle Cells Depends on the COOH-Terminal Region and Glycogen Content

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2221-2226. doi:https://doi.org/10.2337/diabetes.52.9.2221

Signal Transduction

A Novel Insulin Analog With Unique Properties: Lys^B3,Glu^B29 Insulin Induces Prominent Activation of Insulin Receptor Substrate 2, but Marginal Phosphorylation of Insulin Receptor Substrate 1

Irini Rakatzi; Stefanie Ramrath; Daniela Ledwig; Olaf Dransfeld; Thomas Bartels; Gerhard Seipke; Jürgen Eckel

View articletitled, A Novel Insulin Analog With Unique Properties<span class="subtitle-colon">: </span><span class="subtitle">Lys<sup>B3</sup>,Glu<sup>B29</sup> Insulin Induces Prominent Activation of Insulin Receptor Substrate 2, but Marginal Phosphorylation of Insulin Receptor Substrate 1</span>

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2227-2238. doi:https://doi.org/10.2337/diabetes.52.9.2227

Molecular Mechanisms of Insulin Resistance in IRS-2-Deficient Hepatocytes

Angela M. Valverde; Deborah J. Burks; Isabel Fabregat; Tracey L. Fisher; José Carretero; Morris F. White; Manuel Benito

View articletitled, Molecular Mechanisms of Insulin Resistance in IRS-2-Deficient Hepatocytes

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2239-2248. doi:https://doi.org/10.2337/diabetes.52.9.2239

Obesity Studies

Differential Influences of Peroxisome Proliferator–Activated Receptorsγ and -α on Food Intake and Energy Homeostasis

Philip J. Larsen; Per Bo Jensen; Rikke V. Sørensen; Leif Kongskov Larsen; Niels Vrang; Erik M. Wulff; Karsten Wassermann

View articletitled, Differential Influences of Peroxisome Proliferator–Activated Receptorsγ and -α on Food Intake and Energy Homeostasis

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2249-2259. doi:https://doi.org/10.2337/diabetes.52.9.2249

Hyperphagic Effects of Brainstem Ghrelin Administration

Lucy F. Faulconbridge; David E. Cummings; Joel M. Kaplan; Harvey J. Grill

View articletitled, Hyperphagic Effects of Brainstem Ghrelin Administration

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2260-2265. doi:https://doi.org/10.2337/diabetes.52.9.2260

Peripheral, But Not Central, Administration of Adiponectin Reduces Visceral Adiposity and Upregulates the Expression of Uncoupling Protein in Agouti Yellow (A^y/a) Obese Mice

Takayuki Masaki; Seiichi Chiba; Tohru Yasuda; Tetsuo Tsubone; Tetsuya Kakuma; Iichiro Shimomura; Tohru Funahashi; Yuji Matsuzawa; Hironobu Yoshimatsu

View articletitled, Peripheral, But Not Central, Administration of Adiponectin Reduces Visceral Adiposity and Upregulates the Expression of Uncoupling Protein in Agouti Yellow (<em>A<sup>y</sup>/a</em>) Obese Mice

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2266-2273. doi:https://doi.org/10.2337/diabetes.52.9.2266

Immunology and Transplantation

Critical Roles of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand in Type 1 Diabetes

Salah-Eddine Lamhamedi-Cherradi; Shijun Zheng; Roland M. Tisch; Youhai H. Chen

View articletitled, Critical Roles of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand in Type 1 Diabetes

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2274-2278. doi:https://doi.org/10.2337/diabetes.52.9.2274

DcR3/TR6 Effectively Prevents Islet Primary Nonfunction After Transplantation

Yulian Wu; Bing Han; Hongyu Luo; Raphael Roduit; Theodora W. Salcedo; Paul A. Moore; Jun Zhang; Jiangping Wu

View articletitled, DcR3/TR6 Effectively Prevents Islet Primary Nonfunction After Transplantation

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2279-2286. doi:https://doi.org/10.2337/diabetes.52.9.2279

Immunologic Activity in the Small Intestinal Mucosa of Pediatric Patients With Type 1 Diabetes

Mia Westerholm-Ormio; Outi Vaarala; Päivi Pihkala; Jorma Ilonen; Erkki Savilahti

View articletitled, Immunologic Activity in the Small Intestinal Mucosa of Pediatric Patients With Type 1 Diabetes

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2287-2295. doi:https://doi.org/10.2337/diabetes.52.9.2287

Pancreatic-Derived Factor (FAM3B), a Novel Islet Cytokine, Induces Apoptosis of Insulin-Secreting β-Cells

Xiaopei Cao; Zhiyong Gao; Claudia E. Robert; Scott Greene; Gang Xu; Weizhen Xu; Ewan Bell; Don Campbell; Yuan Zhu; Robert Young; Matteo Trucco; James F. Markmann; Ali Naji; Bryan A. Wolf

View articletitled, Pancreatic-Derived Factor (FAM3B), a Novel Islet Cytokine, Induces Apoptosis of Insulin-Secreting β-Cells

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2296-2303. doi:https://doi.org/10.2337/diabetes.52.9.2296

Islet Studies

Increased β-Cell Apoptosis Prevents Adaptive Increase in β-Cell Mass in Mouse Model of Type 2 Diabetes: Evidence for Role of Islet Amyloid Formation Rather Than Direct Action of Amyloid

Alexandra E. Butler; Juliette Janson; Walter C. Soeller; Peter C. Butler

View articletitled, Increased β-Cell Apoptosis Prevents Adaptive Increase in β-Cell Mass in Mouse Model of Type 2 Diabetes<span class="subtitle-colon">: </span><span class="subtitle">Evidence for Role of Islet Amyloid Formation Rather Than Direct Action of Amyloid</span>

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2304-2314. doi:https://doi.org/10.2337/diabetes.52.9.2304

An Insulin-Degrading Enzyme Inhibitor Decreases Amylin Degradation, Increases Amylin-Induced Cytotoxicity, and Increases Amyloid Formation in Insulinoma Cell Cultures

Robert G. Bennett; Frederick G. Hamel; William C. Duckworth

View articletitled, An Insulin-Degrading Enzyme Inhibitor Decreases Amylin Degradation, Increases Amylin-Induced Cytotoxicity, and Increases Amyloid Formation in Insulinoma Cell Cultures

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2315-2320. doi:https://doi.org/10.2337/diabetes.52.9.2315

Pathophysiology

The Hepatic Vagus Mediates Fat-Induced Inhibition of Diabetic Hyperphagia

Susanne E. la Fleur; Hong Ji; Sotara L. Manalo; Mark I. Friedman; Mary F. Dallman

View articletitled, The Hepatic Vagus Mediates Fat-Induced Inhibition of Diabetic Hyperphagia

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2321-2330. doi:https://doi.org/10.2337/diabetes.52.9.2321

Peroxisome Proliferator-Activated Receptor (PPAR)-α Activation Prevents Diabetes in OLETF Rats: Comparison With PPAR-γ Activation

Eun Hee Koh; Min-Seon Kim; Joong-Yeol Park; Hyun Sik Kim; Ji-Young Youn; Hye-Sun Park; Jang Hyun Youn; Ki-Up Lee

View articletitled, Peroxisome Proliferator-Activated Receptor (PPAR)-α Activation Prevents Diabetes in OLETF Rats<span class="subtitle-colon">: </span><span class="subtitle">Comparison With PPAR-γ Activation</span>

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2331-2337. doi:https://doi.org/10.2337/diabetes.52.9.2331

Intramuscular Heat Shock Protein 72 and Heme Oxygenase-1 mRNA Are Reduced in Patients With Type 2 Diabetes: Evidence That Insulin Resistance Is Associated With a Disturbed Antioxidant Defense Mechanism

Clinton R. Bruce; Andrew L. Carey; John A. Hawley; Mark A. Febbraio

View articletitled, Intramuscular Heat Shock Protein 72 and Heme Oxygenase-1 mRNA Are Reduced in Patients With Type 2 Diabetes<span class="subtitle-colon">: </span><span class="subtitle">Evidence That Insulin Resistance Is Associated With a Disturbed Antioxidant Defense Mechanism</span>

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2338-2345. doi:https://doi.org/10.2337/diabetes.52.9.2338

The Metabolic Syndrome and Antioxidant Concentrations: Findings From the Third National Health and Nutrition Examination Survey

Earl S. Ford; Ali H. Mokdad; Wayne H. Giles; David W. Brown

View articletitled, The Metabolic Syndrome and Antioxidant Concentrations<span class="subtitle-colon">: </span><span class="subtitle">Findings From the Third National Health and Nutrition Examination Survey</span>

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2346-2352. doi:https://doi.org/10.2337/diabetes.52.9.2346

Complications

Two Phases of Nitrergic Neuropathy in Streptozotocin-Induced Diabetic Rats

Selim Cellek; Neale A. Foxwell; Salvador Moncada

View articletitled, Two Phases of Nitrergic Neuropathy in Streptozotocin-Induced Diabetic Rats

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2353-2362. doi:https://doi.org/10.2337/diabetes.52.9.2353

Sensory Neurons With Activated Caspase-3 Survive Long-Term Experimental Diabetes

Chu Cheng; Douglas W. Zochodne

View articletitled, Sensory Neurons With Activated Caspase-3 Survive Long-Term Experimental Diabetes

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2363-2371. doi:https://doi.org/10.2337/diabetes.52.9.2363

Neurotrophin-3 Prevents the Proximal Accumulation of Neurofilament Proteins in Sensory Neurons of Streptozocin-Induced Diabetic Rats

Nicola M. Sayers; Lisa J. Beswick; Alicia Middlemas; Nigel A. Calcutt; Andrew P. Mizisin; David R. Tomlinson; Paul Fernyhough

View articletitled, Neurotrophin-3 Prevents the Proximal Accumulation of Neurofilament Proteins in Sensory Neurons of Streptozocin-Induced Diabetic Rats

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2372-2380. doi:https://doi.org/10.2337/diabetes.52.9.2372

S100B-RAGE-Mediated Augmentation of Angiotensin II-Induced Activation of JAK2 in Vascular Smooth Muscle Cells Is Dependent on PLD2

Sean S. Shaw; Ann Marie Schmidt; Amy K. Banes; Xiaodan Wang; David M. Stern; Mario B. Marrero

View articletitled, S100B-RAGE-Mediated Augmentation of Angiotensin II-Induced Activation of JAK2 in Vascular Smooth Muscle Cells Is Dependent on PLD2

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2381-2388. doi:https://doi.org/10.2337/diabetes.52.9.2381

B-Type Natriuretic Peptide Prevents Acute Hypertrophic Responses in the Diabetic Rat Heart: Importance of Cyclic GMP

Anke C. Rosenkranz; Sally G. Hood; Robyn L. Woods; Gregory J. Dusting; Rebecca H. Ritchie

View articletitled, B-Type Natriuretic Peptide Prevents Acute Hypertrophic Responses in the Diabetic Rat Heart<span class="subtitle-colon">: </span><span class="subtitle">Importance of Cyclic GMP</span>

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2389-2395. doi:https://doi.org/10.2337/diabetes.52.9.2389

Effects of Rosuvastatin on Nitric Oxide–Dependent Function in Aorta and Corpus Cavernosum of Diabetic Mice: Relationship to Cholesterol Biosynthesis Pathway Inhibition and Lipid Lowering

Matthew R. Nangle; Mary A. Cotter; Norman E. Cameron

View articletitled, Effects of Rosuvastatin on Nitric Oxide–Dependent Function in Aorta and Corpus Cavernosum of Diabetic Mice<span class="subtitle-colon">: </span><span class="subtitle">Relationship to Cholesterol Biosynthesis Pathway Inhibition and Lipid Lowering</span>

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2396-2402. doi:https://doi.org/10.2337/diabetes.52.9.2396

Genetics

Clinical and Molecular Characterization of a Dominant Form of Congenital Hyperinsulinism Caused by a Mutation in the High-Affinity Sulfonylurea Receptor

Paul S. Thornton; Courtney MacMullen; Arupa Ganguly; Eduardo Ruchelli; Linda Steinkrauss; Ana Crane; Lydia Aguilar-Bryan; Charles A. Stanley

View articletitled, Clinical and Molecular Characterization of a Dominant Form of Congenital Hyperinsulinism Caused by a Mutation in the High-Affinity Sulfonylurea Receptor

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2403-2410. doi:https://doi.org/10.2337/diabetes.52.9.2403

Impaired Cathepsin L Gene Expression in Skeletal Muscle Is Associated With Type 2 Diabetes

Xudong Huang; Allan Vaag; Emma Carlsson; Mona Hansson; Bo Ahrén; Leif Groop

View articletitled, Impaired Cathepsin L Gene Expression in Skeletal Muscle Is Associated With Type 2 Diabetes

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2411-2418. doi:https://doi.org/10.2337/diabetes.52.9.2411

Genome-Wide Linkage Analysis of Serum Adiponectin in the Pima Indian Population

Robert S. Lindsay; Tohru Funahashi; Jonathan Krakoff; Yuji Matsuzawa; Sachiyo Tanaka; Sayuko Kobes; Peter H. Bennett; P. Antonio Tataranni; William C. Knowler; Robert L. Hanson

View articletitled, Genome-Wide Linkage Analysis of Serum Adiponectin in the Pima Indian Population

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2419-2425. doi:https://doi.org/10.2337/diabetes.52.9.2419

Properties of Normal and Mutant Recombinant Human Ketohexokinases and Implications for the Pathogenesis of Essential Fructosuria

Aruna Asipu; Bruce E. Hayward; John O’Reilly; David T. Bonthron

View articletitled, Properties of Normal and Mutant Recombinant Human Ketohexokinases and Implications for the Pathogenesis of Essential Fructosuria

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2426-2432. doi:https://doi.org/10.2337/diabetes.52.9.2426

Insights Into the Biochemical and Genetic Basis of Glucokinase Activation From Naturally Occurring Hypoglycemia Mutations

Anna L. Gloyn; Kees Noordam; Michèl A.A.P. Willemsen; Sian Ellard; Wayne W.K. Lam; Ian W. Campbell; Paula Midgley; Chyio Shiota; Carol Buettger; Mark A. Magnuson; Franz M. Matschinsky; Andrew T. Hattersley

View articletitled, Insights Into the Biochemical and Genetic Basis of Glucokinase Activation From Naturally Occurring Hypoglycemia Mutations

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2433-2440. doi:https://doi.org/10.2337/diabetes.52.9.2433

Brief Genetics Reports

Level of an Advanced Glycated End Product Is Genetically Determined: A Study of Normal Twins

R. David G. Leslie; Huriya Beyan; Pam Sawtell; Bernard O. Boehm; Tim D. Spector; Harold Snieder

View articletitled, Level of an Advanced Glycated End Product Is Genetically Determined<span class="subtitle-colon">: </span><span class="subtitle">A Study of Normal Twins</span>

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2441-2444. doi:https://doi.org/10.2337/diabetes.52.9.2441

Genetic Variation of the GLUT10 Glucose Transporter (SLC2A10) and Relationships to Type 2 Diabetes and Intermediary Traits

Gitte Andersen; Christian Schack Rose; Yasmin Hassan Hamid; Thomas Drivsholm; Knut Borch-Johnsen; Torben Hansen; Oluf Pedersen

View articletitled, Genetic Variation of the GLUT10 Glucose Transporter (<em>SLC2A10</em>) and Relationships to Type 2 Diabetes and Intermediary Traits

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2445-2448. doi:https://doi.org/10.2337/diabetes.52.9.2445

Erratum

Errata

View articletitled, Errata

Open the PDF for in another window

Diabetes September 2003, Vol.52, 2449. doi:https://doi.org/10.2337/diabetes.52.9.2449

Email alerts

Online Ahead of Print Alert

Latest Issue Alert

RSS Feeds

Current Issue RSS Feed

RSS Feed - Advance Access

Most Read
Most Cited

Système International (SI) Units Table

Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel

713-P: Is There a Correct Time to Measure Fasting Blood Sugar in Persons with Type 2 Diabetes Melitus?

300-OR: Beneficial Effect of the Combination Therapy of Cagrilintide, a Dual Amylin/Calcitonin Agonist, and Tirzepatide, a Dual GLP-1/GIP Agonist, on Body Weight Loss in Obese Rats

Elevated First-Trimester Neutrophil Count Is Closely Associated With the Development of Maternal Gestational Diabetes Mellitus and Adverse Pregnancy Outcomes

Online ISSN 1939-327X
Print ISSN 0012-1797

Journals

Diabetes
Diabetes Care
Clinical Diabetes
Diabetes Spectrum
Standards of Medical Care in Diabetes
Scientific Sessions Abstracts
BMJ Open Diabetes Research & Care

Books

ShopDiabetes.org
ADA Professional Books

Clinical Compendia

Clinical Compendia Home

News

Latest News
DiabetesPro SmartBrief

Podcasts

Diabetes Core Update
Diabetes Care "On Air"
DiabetesBio
Diabetes Day by Day
Diabetes Core Update: Special Editions

Other

Special Collections
DiabetesPro®
Diabetes Food Hub™
Insulin Affordability
Know Diabetes By Heart™

About

About the ADA
Journal Policies
For Reviewers
Advertising in ADA Journals
Reprints and Permission for Reuse
Copyright Notice/Public Access Policy

Resources

ADA Professional Membership
ADA Member Directory
Diabetes.org

X (Twitter)
Facebook
LinkedIn

Contact Us
Cookie Policy
Accessibility
Terms & Conditions
Get Adobe Acrobat Reader
© Copyright American Diabetes Association

This Feature Is Available To Subscribers Only

Sign In or Create an Account

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.

Accept